X-chromosome-located microRNAs in immunity: Might they explain male/female differences?: The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females

BioEssays

Volumn 33, Issue 11, 2011, Pages 791-802

  Pinheiro, Iris ^a,b   Dejager, Lien ^a,b   Libert, Claude ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Cancer; Genomic context; Immunity; MiRNAs; X chromosome

Indexed keywords

MICRORNA;

ARTICLE; CARCINOGENESIS; GENOME; HUMAN; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; SEX CHROMOSOMAL INHERITANCE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; X CHROMOSOME; X CHROMOSOME LINKAGE;

ANIMALS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, X-LINKED; GENOME, HUMAN; HUMANS; IMMUNITY; MALE; MICE; MICRORNAS; MUTATION; NEOPLASMS; SEX FACTORS; SIGNAL TRANSDUCTION; X CHROMOSOME;

EID: 80054694532     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201100047     Document Type: Article

References (90)

1. Gannon CJ, Pasquale M, Tracy JK, McCarter RJ, et al. 2004. Male gender is associated with increased risk for postinjury pneumonia. Shock 21: 410-4.
2. Choudhry MA, Bland KI, Chaudry IH. 2006. Gender and susceptibility to sepsis following trauma. Endocr Metab Immune Disord Drug Targets 6: 127-35.
3. George RL, McGwin G, Windham ST, Melton SM, et al. 2003. Age-related gender differential in outcome after blunt or penetrating trauma. Shock 19: 28-32.
4. Bone RC. 1992. Toward an epidemiology and natural-history of SIRS (Systemic Inflammatory Response Syndrome). JAMA-J Am Med Assoc 268: 3452-5.
5. Schröder J, Kahlke V, Staubach KH, Zabel P, et al. 1998. Gender differences in human sepsis. Arch Surg-Chicago 133: 1200-4.
6. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. 2000. Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intens Care Med 26: 167-72.
7. Migeon BR. 2007. Why females are mosaics, X-chromosome inactivation, and sex differences in disease. Gend Med 4: 97-105.
8. Morris JA, Harrison LM. 2009. Hypothesis: increased male mortality caused by infection is due to a decrease in heterozygous loci as a result of a single X chromosome. Med Hypotheses 72: 322-4.
9. Lockshin MD. 2006. Sex differences in autoimmune disease. Lupus 15: 753-6.
10. Ozcelik T. 2008. X chromosome inactivation and female predisposition to autoimmunity. Clin Rev Allergy Immunol 34: 348-51.
11. Libert C, Dejager L, Pinheiro I. 2010. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol 10: 594-604.
12. Kovacs EJ, Messingham KA, Gregory MS. 2002. Estrogen regulation of immune responses after injury. Mol Cell Endocrinol 193: 129-35.
13. Palaszynski KM, Smith DL, Kamrava S, Burgoyne PS, et al. 2005. A Yin-Yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 146: 3280-5.
14. Carrel L, Willard HF. 2005. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434: 400-4.
15. Orstavik KH. 2009. X chromosome inactivation in clinical practice. Hum Genet 126: 363-73.
16. Fish EN. 2008. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 8: 737-44.
17. Pessach IM, Notarangelo LD. 2009. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun 33: 17-24.
18. Migeon BR. 2007. Females are Mosaics: X Inactivation and Sex Differences in Disease. New York: Oxford University Press, Inc. 271 p.
19. Spolarics Z. 2007. The X-files of inflammation: cellular mosaicism of X-linked polymorphic genes and the female advantage in the host response to injury and infection. Shock 27: 597-604.
20. Denli AM, Tops BBJ, Plasterk RHA, Ketting RF, et al. 2004. Processing of primary microRNAs by the Microprocessor complex. Nature 432: 231-5.
21. Lee Y, Ahn C, Han JJ, Choi H, et al. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-9.
22. Yi R, Qin Y, Macara IG, Cullen BR. 2003. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Gene Dev 17: 3011-6.
23. Zhang HD, Kolb FA, Jaskiewicz L, Westhof E, et al. 2004. Single processing center models for human dicer and bacterial RNase III. Cell 118: 57-68.
24. Zeng Y. 2006. Principles of micro-RNA production and maturation. Oncogene 25: 6156-62.
25. Bartel DP. 2009. MicroRNAs target recognition and regulatory functions. Cell 136: 215-33.
26. Ohno S. 1967. In Labhart A, Mann T, Samuels LT, Zander J, eds; Sex Chromosomes and Sex-Linked Genes. Berlin: Springer-Verlag.
27. Ross MT, Grafham DV, Coffey AJ, Scherer S, et al. 2005. The DNA sequence of the human X chromosome. Nature 434: 325-37.
28. Wang PJ, McCarrey JR, Yang F, Page DC. 2001. An abundance of X-linked genes expressed in spermatogonia. Nat Genet 27: 422-6.
29. Zechner U, Wilda M, Kehrer-Sawatzki H, Vogel W, et al. 2001. A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution? Trends Genet 17: 697-701.
30. Migeon BR. 2006. The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases. JAMA 295: 1428-33.
31. Koker MY, Sanal O, de Boer M, Tezcan I, et al. 2006. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family. Eur J Clin Invest 36: 257-64.
32. Weber B, Stresemann C, Brueckner B, Lyko F. 2007. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6: 1001-5.
33. Brueckner B, Stresemann C, Kuner R, Mund C, et al. 2007. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67: 1419-23.
34. Lujambio A, Esteller M. 2007. CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 6: 1455-9.
35. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
36. Chekulaeva M, Filipowicz W. 2009. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21: 452-60.
37. Guo XJ, Su B, Zhou ZM, Sha JH. 2009. Rapid evolution of mammalian X-linked testis microRNAs. BMC Genomics 10: 97.
38. Welker NC, Habig JW, Bass BL. 2007. Genes misregulated in C. elegans deficient in Dicer, RDE-4, or RDE-1 are enriched for innate immunity genes. RNA 13: 1090-102.
39. Zhang R, Peng Y, Wang W, Su B. 2007. Rapid evolution of an X-linked microRNA cluster in primates. Genome Res 17: 612-7.
40. Sonkoly E, Stahle M, Pivarcsi A. 2008. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18: 131-40.
41. Heimberg AM, Sempere LF, Moy VN, Donoghue PCJ, et al. 2008. MicroRNAs and the advent of vertebrate morphological complexity. Proc Natl Acad Sci USA 105: 2946-50.
42. Li SC, Tang P, Lin WC. 2007. Intronic MicroRNA: discovery and biological implications. DNA Cell Biol 26: 195-207.
43. Ying SY, Lin SL. 2005. Intronic microRNAs. Biochem Biophys Res Co 326: 515-20.
44. Ying SY, Lin SL. 2006. Current perspectives in intronic micro RNAs (miRNAs). J Biomed Sci 13: 5-15.
45. Cho WC. 2007. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60.
46. Esquela-Kerscher A, Slack FJ. 2006. OncomiRs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-69.
47. Kluiver J, Poppema S, de Jong D, Blokzijl T, et al. 2005. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207: 243-9.
48. Zhao JL, Rao DS, Boldin MP, Taganov KD, et al. 2011. NF-kappa B dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci USA 108: 9184-9.
49. Lindsay MA. 2008. microRNAs and the immune response. Trends Immunol 29: 343-51.
50. Pedersen I, David M. 2008. MicroRNAs in the immune response. Cytokine 43: 391-4.
51. Tsitsiou E, Lindsay MA. 2009. microRNAs and the immune response. Curr Opin Pharmacol 9: 514-20.
52. Kundu JK, Surh YJ. 2008. Inflammation: gearing the journey to cancer. Mutat Res 659: 15-30.
53. Cobb BS, Hertweck A, Smith J, O'Connor E, et al. 2006. A role for Dicer in immune regulation. J Exp Med 203: 2519-27.
54. Koralov SB, Muljo SA, Galler GR, Krek A, et al. 2008. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-74.
55. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, et al. 2005. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 202: 261-9.
56. Ashley DJB. 1969. A male-female differential in tumour incidence. Brit J Cancer 23: 21-5.
57. Greenberg RS, Shuster JL. 1985. Epidemiology of cancer in children. Epidemiol Rev 7: 22-48.
58. Pearce MS, Parker L. 2001. Childhood cancer registrations in the developing world: still more boys than girls. Int J Cancer 91: 402-6.
59. Cartwright RA, Gurney KA, Moorman AV. 2002. Sex ratios and the risks of haematological malignancies. Brit J Haematol 118: 1071-7.
60. Cook MB, Dawsey SM, Freedman ND, Inskip PD, et al. 2009. Sex disparities in cancer incidence by period and age. Cancer Epidem Biomar 18: 1174-82.
61. le Sage C, Nagel R, Egan DA, Schrier M, et al. 2007. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-708.
62. Poliseno L, Tuccoli A, Mariani L, Evangelista M, et al. 2006. MicroRNAs modulate the angiogenic properties of HLTVECs. Blood 108: 3068-71.
63. Urbich C, Kuehbacher A, Dimmeler S. 2008. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-8.
64. Fazi F, Rosa A, Fatica A, Gelmetti V, et al. 2005. A minicircuitry comprised of MicroRNA-223 and transcription factors NFI-A and C/EBP alpha regulates human granulopoiesis. Cell 123: 819-31.
65. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, et al. 2008. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-9.
66. Moschos SA, Williams AE, Perry MM, Birrell MA, et al. 2007. Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 8: 240.
67. Wang JF, Yu ML, Yu G, Bian JJ, et al. 2010. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 394: 184-8.
68. Fontana L, Pelosi E, Greco P, Racanicchi S, et al. 2007. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 9: 775-87.
69. Sharma A, Kumar M, Aich J, Hariharan M, et al. 2009. Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Proc Natl Acad Sci USA 106: 5761-6.
70. Tanzer A, Stadler PF. 2004. Molecular evolution of a microRNA cluster. J Mol Biol 339: 327-35.
71. Landais S, Landry S, Legault P, Rassart E. 2007. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67: 5699-707.
72. Rosa A, Ballarino M, Sorrentino A, Sthandier O, et al. 2007. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci USA 104: 19849-54.
73. Schmeier S, MacPherson CR, Essack M, Kaur M, et al. 2009. Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation. BMC Genomics 10: 595.
74. Forrest ARR, Kanamori-Katayama M, Tomaru Y, Lassmann T, et al. 2010. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24: 460-6.
75. Lleo A, Battezzati PM, Selmi C, Gershwin ME, et al. 2008. Is autoimmunity a matter of sex? Autoimmun Rev 7: 626-30.
76. Lin SL, Miller JD, Ying SY. 2006. IntronicMicroRNA (miRNA). J Biomed Biotechnol 2006: 1-13.
77. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, et al. 2001. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293: 864-7.
78. Jin P, Alisch RS, Warren ST. 2004. RNA and microRNAs in fragile X mental retardation. Nat Cell Biol 6: 1048-53.
79. Tong AW, Nemunaitis J. 2008. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-55.
80. Arcaroli J, Silva E, Maloney JP, He QB, et al. 2006. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappa B activation and worse outcomes in sepsis. Am J Respir Crit Care Med 173: 1335-41.
81. Berglund M, Thomas JA, Fredin MF, Melgar S, et al. 2009. Gender dependent importance of IRAK-1 in dextran sulfate sodium induced colitis. Cell Immunol 259: 27-32.
82. Uzel G. 2005. The range of defects associated with nuclear factor kappa B essential modulator. Curr Opin Allergy Clin Immunol 5: 513-8.
83. Berrebi D, Bruscoli S, Cohen N, Foussat A, et al. 2003. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101: 729-38.
84. Hamdi H, Bigorgne A, Naveau S, Balian A, et al. 2007. Glucocorticoid-induced leucine zipper: a key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis. Hepatology 46: 1986-92.
85. Mittelstadt PR, Ashwell JD. 2001. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276: 29603-10.
86. Cannarile L, Cuzzocrea S, Santucci L, Agostini M, et al. 2009. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 136: 530-41.
87. Beaulieu E, Ngo D, Santos L, Yang YH, et al. 2010. Glucocorticoid-induced leucine zipper is an endogenous anti-inflammatory mediator in arthritis. Arthritis Rheum 62: 2651-61.
88. Berghofer B, Frommer T, Haley G, Fink L, et al. 2006. TLR7 Ligands induce higher IFN-alpha production in females. J Immunol 177: 2088-96.
89. Davila S, Hibberd ML, Dass RH, Wong HEE, et al. 2008. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet 4: e1000218.
90. Oh DY, Taube S, Hamouda O, Kuecherer C, et al. 2008. A functional toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis 198: 701-9.